Completed
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
NCT00589784
- Conditions
- Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States
- Memorial Sloan-Kettering Cancer Center New York, United States